Erste Asset Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-35,600
| Closed | -$879K | – | 881 |
|
|
2022
Q2 | $879K | Hold |
35,600
| – | – | 0.02% | 372 |
|
|
2022
Q1 | $894K | Hold |
35,600
| – | – | 0.02% | 367 |
|
|
2021
Q4 | $1.09M | Hold |
35,600
| – | – | 0.02% | 349 |
|
|
2021
Q3 | $854K | Hold |
35,600
| – | – | 0.02% | 348 |
|
|
2021
Q2 | $532K | Hold |
35,600
| – | – | 0.01% | 403 |
|
|
2021
Q1 | $866K | Hold |
35,600
| – | – | 0.02% | 341 |
|
|
2020
Q4 | $963K | Hold |
35,600
| – | – | 0.03% | 339 |
|
|
2020
Q3 | $663K | Hold |
35,600
| – | – | 0.02% | 332 |
|
|
2020
Q2 | $702K | Hold |
35,600
| – | – | 0.03% | 320 |
|
|
2020
Q1 | $507K | Hold |
35,600
| – | – | 0.03% | 306 |
|
|
2019
Q4 | $512K | Hold |
35,600
| – | – | 0.02% | 327 |
|
|
2019
Q3 | $423K | Hold |
35,600
| – | – | 0.02% | 329 |
|
|
2019
Q2 | $715K | Hold |
35,600
| – | – | 0.04% | 276 |
|
|
2019
Q1 | $820K | Sell |
35,600
-8,400
| -19% | -$193K | 0.05% | 263 |
|
|
2018
Q4 | $979K | Buy |
+44,000
| New | +$979K | 0.07% | 239 |
|